RADIOPHARMACEUTICAL MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-180258 |   Reports

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Radiopharmaceutical Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL RADIOPHARMACEUTICAL MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL RADIOPHARMACEUTICAL MARKET

7.1 GLOBAL RADIOPHARMACEUTICAL MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA RADIOPHARMACEUTICAL MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Lantheus Medical Imaging

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Inc

16.3 GE Healthcare

16.4 Advanced Accelerator Applications

16.5 Mallinckrodt

16.6 Bayer AG

16.7 Siemens Healthineers

16.8 IBA Radiopharma Solutions

16.9 Eckert & Ziegler

16.10 Philips

16.11 Jubilant Life Sciences Limited

16.12 Novartis AG

16.13 BWX Technologies

16.14 Inc.

16.15 POLATOM

16.16 JSC Isotope

16.17 NTP Radioisotopes SOC Ltd

16.18 Curium

16.19 Australian Nuclear Science and Technology Organization (ANSTO)

16.20 Cardinal Health Inc.

16.21 Covidien Plc

16.22 Positron Corporation

16.23 Monrol Nuclear Products,Inc

16.24 and Nordion

16.25 Inc.

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Sources Covered:
• Nuclear Reactors
• Cyclotrons

Types Covered:
• Therapeutic
• Diagnostic

Radioisotopes Covered:
• Yttrium-90
• Thallium-201
• Technetium-99
• Strontium -89
• Samarium-153
• Rubidium-82
• Rhenium-186
• Radium-223
• Palladium - 103
• Leutetium-177
• Iridium - 192
• Iodine-131
• Iodine-125
• Iodine-123
• Indium-111
• Holmium-166
• Gallium-68
• Gallium-67
• Fluorine-18
• Fludeoxyglucose - (18F-FDG)
• Erbium-169
• Cesium-131
• Actinium-225

Applications Covered:
• Thyroid
• Theranostics
• Oncology
• Neurology
• Neuroendocrinology
• Nephrology
• Lymphoma
• Inflammation
• Gastroenterology
• Cardiology

End Users Covered:
• Ambulatory Surgical Centers
• Cancer Research Institute
• Diagnostic Imaging Centers
• Hospitals

Companies

Lantheus Medical Imaging
Inc
GE Healthcare
Advanced Accelerator Applications
Mallinckrodt
Bayer AG
Siemens Healthineers
IBA Radiopharma Solutions
Eckert & Ziegler
Philips
Jubilant Life Sciences Limited
Novartis AG
BWX Technologies
Inc.
POLATOM
JSC Isotope
NTP Radioisotopes SOC Ltd
Curium
Australian Nuclear Science and Technology Organization (ANSTO)
Cardinal Health Inc.
Covidien Plc
Positron Corporation
Monrol Nuclear Products,Inc
and Nordion
Inc.

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.